Mgta-117, an Anti-CD117-Amanitin Antibody-Drug Conjugate, in Participants with Relapsed/Refractory Adult Acute Myeloid Leukemia (AML) and Myelodysplasia with Excess Blasts (MDS-EB): Safety, Pharmacokinetics, and Pharmacodynamics Initial Findings from a Phase 1/2 Study

Autor:	Mark Juckett, Peter Westervelt, Partow Kebriaei, Andrew S. Artz, Onyee Chan, Dr. Philip L. McCarthy, Sherif S. Farag, Anurag K. Singh, Eytan Stein, Ji Hyun Lee, Alison Occhiuti, Jeanie Tang, David Santos, Kirk Bertelsen, Balaji Mahender, Nicole Henry, Donald Pardy, June Li, Christian Zdybowicz, Shawn Rose
Rok vydání:	2023
Předmět:	Transplantation Molecular Medicine Immunology and Allergy Cell Biology Hematology
Zdroj:	Transplantation and Cellular Therapy. 29:S109-S110
ISSN:	2666-6367
DOI:	10.1016/s2666-6367(23)00205-1
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::510cf7f0b3469505b8e6c11756fcdea3 https://doi.org/10.1016/s2666-6367(23)00205-1 Zobrazit plný text záznamu Full Text from ScienceDirect